Evaluation of early percutaneous coronary intervention vs. standard therapy after fibrinolysis for ST-segment elevation myocardial infarction: Contribution of weighting the composite endpoint

24Citations
Citations of this article
43Readers
Mendeley users who have this article in their library.

Abstract

AimsThe selection of optimal endpoints for cardiovascular clinical trials continues to be challenging. We examined an alternative interpretation of a series of trials when the individual event severity is considered.Methods and resultsWe analysed three contemporary myocardial infarction (MI) trials of early percutaneous coronary intervention after fibrinolysis, using a weighted composite method. This method allows the examination of the heterogeneity in the direction and magnitude of component endpoints, and multiple events (vs. first event). We incorporated a physician-assessed severity of each component endpoint in all patients for the five-item composite in the largest study, Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI), which enrolled 1059 ST-elevation MI patients. The traditional approach yielded event-free survival probabilities of 0.89 [95% confidence interval (CI) 0.86-0.91] for the early invasive arm and 0.83 (95% CI 0.79-0.86) for the standard care arm (P = 0.004). After accounting for the clinician-investigator-determined weights, the effective survival probabilities were 0.93 (95% CI 0.91-0.95) for the early invasive arm and 0.93 (95% CI 0.90-0.95) with no significant difference (P = 0.54). The same pattern was observed in the three-trial cohort using a four-item composite with an observed improvement in event-free survival outcomes (P = 0.01), which was no longer apparent after the severity weights were considered (P = 0.44).ConclusionThis analysis highlights the importance of considering the relative severity and multiple events in the evaluation of a clinical trial. All rights reserved. © 2012 The Author.

References Powered by Scopus

Universal definition of myocardial infarction

1863Citations
N/AReaders
Get full text

Composite Outcomes in Randomized Trials: Greater Precision but with Greater Uncertainty?

615Citations
N/AReaders
Get full text

The win ratio: A new approach to the analysis of composite endpoints in clinical trials based on clinical priorities

482Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Reduction in Total Cardiovascular Events with Ezetimibe/Simvastatin Post-Acute Coronary Syndrome the IMPROVE-IT Trial

178Citations
N/AReaders
Get full text

Composite End Points in Clinical Research: A Time for Reappraisal

87Citations
N/AReaders
Get full text

Individual and composite study endpoints: Separating the wheat from the chaff

49Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Bakal, J. A., Westerhout, C. M., Cantor, W. J., Fernández-Avilés, F., Welsh, R. C., Fitchett, D., … Armstrong, P. W. (2013). Evaluation of early percutaneous coronary intervention vs. standard therapy after fibrinolysis for ST-segment elevation myocardial infarction: Contribution of weighting the composite endpoint. European Heart Journal, 34(12), 903–908. https://doi.org/10.1093/eurheartj/ehs438

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 9

43%

Professor / Associate Prof. 6

29%

Researcher 6

29%

Readers' Discipline

Tooltip

Medicine and Dentistry 17

74%

Nursing and Health Professions 2

9%

Agricultural and Biological Sciences 2

9%

Economics, Econometrics and Finance 2

9%

Save time finding and organizing research with Mendeley

Sign up for free